Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis

被引：0
作者：
Georg Auzinger
E. Geoffrey Playford
Christopher N. Graham
Hediyyih N. Knox
David Weinstein
Michal Kantecki
Haran Schlamm
Claudie Charbonneau
机构：
[1] King’s College Hospital,
[2] Princess Alexandra Hospital,undefined
[3] RTI Health Solutions,undefined
[4] Research Triangle Park,undefined
[5] Pfizer International Operations,undefined
[6] Pfizer Inc,undefined
来源：
BMC Infectious Diseases | / 15卷
关键词：
Anidulafungin; Candidaemia; Echinocandin; Invasive Candidiasis; Cost-Effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS ANALYSIS OF ANTIEMETIC TREATMENT
    BLEIBERG, H
    AUTIER, P
    MICHAUX, D
    SUPPORTIVE CARE IN CANCER, 1994, 2 (03) : 145 - 149
  • [22] Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies
    Kontoyiannis, Dimitrios P.
    Bassetti, Matteo
    Nucci, Marcio
    Capparella, Maria Rita
    Yan, Jean L.
    Aram, Jalal
    Hogan, Patricia A.
    MYCOSES, 2017, 60 (10) : 663 - 667
  • [23] Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
    Lefteris Floros
    Daniel Kuessner
    Jan Posthumus
    Emma Bagshaw
    Jan Sjölin
    BMC Infectious Diseases, 19
  • [24] Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
    Floros, Lefteris
    Kuessner, Daniel
    Posthumus, Jan
    Bagshaw, Emma
    Sjolin, Jan
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [25] Candidemia and invasive candidiasis in the adult: Clinical forms and treatment
    Cervera, Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2012, 30 (08): : 483 - 491
  • [26] A Cost-Effectiveness Analysis of Pegcetacoplan for the Treatment of Geographic Atrophy
    Patel, Nimesh A.
    Al-Khersan, Hasenin
    Yannuzzi, Nicolas A.
    Lin, James
    Smiddy, William E.
    OPHTHALMOLOGY RETINA, 2024, 8 (01): : 25 - 31
  • [27] Cost-effectiveness analysis of optimal strategy for tumor treatment
    Pang, Liuyong
    Zhao, Zhong
    Song, Xinyu
    CHAOS SOLITONS & FRACTALS, 2016, 87 : 293 - 301
  • [28] Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico
    Arreola Ornelas, Hector
    Rosado Buzzo, Alfonso
    Garcia, Lourdes
    Dorantes Aguilar, Javier
    Contreras Hernandez, Iris
    Mould Quevedo, Joaquin F.
    REUMATOLOGIA CLINICA, 2012, 8 (03): : 120 - 127
  • [29] Treatment for early endometrial cancer - Cost-effectiveness analysis
    Fanning, J
    JOURNAL OF REPRODUCTIVE MEDICINE, 1999, 44 (08) : 719 - 723
  • [30] Treatment of migraine in Canada with naratriptan: A cost-effectiveness analysis
    Caro, JJ
    Getsios, D
    Raggio, G
    Caro, G
    Black, L
    HEADACHE, 2001, 41 (05): : 456 - 464
12345